HIGH DOSE METHOTREXATE (HD-MTX) IN TREATMENT OF EXTRA-RENAL RHABDOID TUMOR (ERRT) WITH DIFFUSE LEPTOMENINGEAL SPREAD

被引：0
|
作者：
Saeed, Haleema [1 ]
Hord, Jeffrey [1 ]
机构：
[1] Akron Childrens Hosp, Akron, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] IMPROVED SURVIVAL IN PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF HEAD AND NECK RESPONDING TO PREOPERATIVE HIGH-DOSE METHOTREXATE-LEUKOVORIN (HD-MTX)
    ERVIN, TJ
    MILLER, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 141 - 141
  • [32] Evaluation of simplified preanalytical Conditions for the Determination of Methotrexate (MTX) and MTX Metabolites by Liquid Chromatography / Tandem Mass Spectrometry (LC-MS/MS) in Blood Samples from Patients after High-dose MTX Therapy (HD-MTX) and Glucarpidase Treatment
    Knoernschild, F.
    Merz, I
    Jahic, A.
    Kiessling, P.
    Kappert, K.
    Keller, U.
    Schwartz, S.
    Liebig, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 162 - 162
  • [33] Phase I evaluation of infusional BUdR with accelerated fractionation radiation therapy following IDHAP chemotherapy with high-dose methotrexate (HD-MTX) for the treatment of primary CNS lymphoma
    Dabaja, BS
    McLaughlin, P
    Ha, CS
    Myers, C
    Wilder, RB
    Kyritsis, A
    RADIOLOGY, 2001, 221 : 552 - 552
  • [34] TREATMENT OF CHILDHOOD NON-HODGKINS LYMPHOMA WITH MULTI-DRUG COMBINATION PROTOCOL INCLUDING HIGH-DOSE METHOTREXATE (HD-MTX) AND CITROVORUM FACTOR (CF) RESCUE
    SASAKI, K
    NINOMIYA, T
    FUJIMOTO, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 193 - 193
  • [35] No Benefit of High Dose Methotrexate (HD-MTX) in Intermediate Risk Childhood Acute Lymphoblastic Leukemia (ALL): Results of 2 Randomised Multicenter Trials in Russia
    Karachunskiy, A.
    Ponomareva, N.
    Roumiantseva, J.
    Aleynikova, O.
    Arakaev, O.
    Litvinov, D.
    Karelin, A.
    Boychenko, E.
    Sharapova, G.
    Lagoyko, S.
    Bydanov, O.
    Henze, G.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S27 - S27
  • [36] ATYPICAL PRESENTATION OF CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (CIAE) AFTER TREATMENT WITH HIGH DOSE METHOTREXATE (HD MTX)
    Vatsayan, Anant
    Lin, Chia-Lei
    Honda, Kord
    Norris, Robin
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 78 - 78
  • [37] PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
    Schaff, Lauren
    Lobbous, Mina
    Bozza, Alexis
    Carlow, Dean
    Nabors, Louis
    Grommes, Christian
    NEURO-ONCOLOGY, 2020, 22 : 25 - 26
  • [38] COMPARATIVE OUTCOME OF CHILDHOOD OSTEOSARCOMA TREATED WITH 2 CONSECUTIVE PROTOCOLS: HIGHLIGHTING THE EFFECTIVENESS OF HIGH-DOSE METHOTREXATE (HD-MTX) IN A SINGLE INSTITUTE'S EXPERIENCE
    Worawut, C.
    Pakakasama, S.
    Hongeng, S.
    Hutsadol, S.
    Sirachainan, N.
    Chuansumrit, A.
    Anurathapan, U.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 88 - 88
  • [39] Orelabrutinib, Rituximab, and High-Dose Methotrexate (HD-MTX) in Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis on Efficacy, Safety, and Biomarker
    Zhao, Shihua
    Liu, Yao
    Zhu, Zunmin
    He, Jianxia
    Liu, Lihong
    Wang, Xiaobo
    Zhao, Yuxia
    Hu, Chongling
    Yuan, Xiaoli
    Bai, Sijun
    Geng, Ye
    Huang, Wenrong
    BLOOD, 2022, 140 : 1338 - 1339
  • [40] HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
    Abu Arja, Mohammad H.
    Mehyar, Lubna S.
    Osorio, Diana S.
    Coven, Scott
    Gardner, Sharon
    Finlay, Jonathan L.
    NEURO-ONCOLOGY, 2018, 20 : 124 - 124
12345